L'accesso ai dati della ricerca: Una luce in fondo al tunnel?

Translated title of the contribution: Access to research data: A light at the end of the tunnel?

Paolo Vercellini, Laura Buggio

Research output: Contribution to journalArticle

Abstract

The recent update of a systematic review conducted by a group of researchers from the Cochrane Collaboration showed modest effectiveness of neuraminidase inhibitors in reducing hospitalizations in patients with influenza, and an even smaller impact of these drugs on overall mortality. However, the relevance of this systematic review mainly relies on the revolutionary methodology with which it was performed, as it included among the evidence considered findings from unpublished clinical study reports submitted by pharmaceutical companies to regulatory agencies. The paper by Jefferson et al. published in the BMJ as well as the campaigns supported by the same journal open a new phase that should bring greater transparency in the relationship between researchers, industry and government to the benefit of citizens. Copyright - Il Pensiero Scientifico Editore.

Original languageItalian
Pages (from-to)184-186
Number of pages3
JournalRecenti Progressi in Medicina
Volume105
Issue number5
DOIs
Publication statusPublished - 2014

Fingerprint

Research Personnel
Neuraminidase
Research
Pharmaceutical Preparations
Human Influenza
Industry
Hospitalization
Mortality
Clinical Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

L'accesso ai dati della ricerca : Una luce in fondo al tunnel? / Vercellini, Paolo; Buggio, Laura.

In: Recenti Progressi in Medicina, Vol. 105, No. 5, 2014, p. 184-186.

Research output: Contribution to journalArticle

@article{75c5c84bd3d94c7d9172d3451b1aca2a,
title = "L'accesso ai dati della ricerca: Una luce in fondo al tunnel?",
abstract = "The recent update of a systematic review conducted by a group of researchers from the Cochrane Collaboration showed modest effectiveness of neuraminidase inhibitors in reducing hospitalizations in patients with influenza, and an even smaller impact of these drugs on overall mortality. However, the relevance of this systematic review mainly relies on the revolutionary methodology with which it was performed, as it included among the evidence considered findings from unpublished clinical study reports submitted by pharmaceutical companies to regulatory agencies. The paper by Jefferson et al. published in the BMJ as well as the campaigns supported by the same journal open a new phase that should bring greater transparency in the relationship between researchers, industry and government to the benefit of citizens. Copyright - Il Pensiero Scientifico Editore.",
author = "Paolo Vercellini and Laura Buggio",
year = "2014",
doi = "10.1701/1493.16449",
language = "Italian",
volume = "105",
pages = "184--186",
journal = "Recenti Progressi in Medicina",
issn = "0034-1193",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "5",

}

TY - JOUR

T1 - L'accesso ai dati della ricerca

T2 - Una luce in fondo al tunnel?

AU - Vercellini, Paolo

AU - Buggio, Laura

PY - 2014

Y1 - 2014

N2 - The recent update of a systematic review conducted by a group of researchers from the Cochrane Collaboration showed modest effectiveness of neuraminidase inhibitors in reducing hospitalizations in patients with influenza, and an even smaller impact of these drugs on overall mortality. However, the relevance of this systematic review mainly relies on the revolutionary methodology with which it was performed, as it included among the evidence considered findings from unpublished clinical study reports submitted by pharmaceutical companies to regulatory agencies. The paper by Jefferson et al. published in the BMJ as well as the campaigns supported by the same journal open a new phase that should bring greater transparency in the relationship between researchers, industry and government to the benefit of citizens. Copyright - Il Pensiero Scientifico Editore.

AB - The recent update of a systematic review conducted by a group of researchers from the Cochrane Collaboration showed modest effectiveness of neuraminidase inhibitors in reducing hospitalizations in patients with influenza, and an even smaller impact of these drugs on overall mortality. However, the relevance of this systematic review mainly relies on the revolutionary methodology with which it was performed, as it included among the evidence considered findings from unpublished clinical study reports submitted by pharmaceutical companies to regulatory agencies. The paper by Jefferson et al. published in the BMJ as well as the campaigns supported by the same journal open a new phase that should bring greater transparency in the relationship between researchers, industry and government to the benefit of citizens. Copyright - Il Pensiero Scientifico Editore.

UR - http://www.scopus.com/inward/record.url?scp=84903208981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903208981&partnerID=8YFLogxK

U2 - 10.1701/1493.16449

DO - 10.1701/1493.16449

M3 - Articolo

C2 - 24873940

AN - SCOPUS:84903208981

VL - 105

SP - 184

EP - 186

JO - Recenti Progressi in Medicina

JF - Recenti Progressi in Medicina

SN - 0034-1193

IS - 5

ER -